Stock Analysis

Science in Sport Full Year 2023 Earnings: UK£0.066 loss per share (vs UK£0.079 loss in FY 2022)

AIM:SIS
Source: Shutterstock

Science in Sport (LON:SIS) Full Year 2023 Results

Key Financial Results

  • Revenue: UK£62.7m (down 1.7% from FY 2022).
  • Net loss: UK£11.3m (loss widened by 3.4% from FY 2022).
  • UK£0.066 loss per share.
earnings-and-revenue-history
AIM:SIS Earnings and Revenue History June 30th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Science in Sport Earnings Insights

Looking ahead, revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 3.5% growth forecast for the Personal Products industry in the United Kingdom.

Performance of the British Personal Products industry.

The company's shares are up 2.7% from a week ago.

Risk Analysis

You should learn about the 3 warning signs we've spotted with Science in Sport (including 1 which makes us a bit uncomfortable).

Valuation is complex, but we're helping make it simple.

Find out whether Science in Sport is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're helping make it simple.

Find out whether Science in Sport is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About AIM:SIS

Science in Sport

Develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community in the United Kingdom, rest of Europe, the United States, and internationally.

Adequate balance sheet and slightly overvalued.